Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Small Cell Lung Carcinoma × Carboplatin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 62 OTHER 57 NIH 4 OTHER_GOV 2 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 31 Lung Neoplasms 27 Ovarian Neoplasms 21 Carcinoma, Ovarian Epithelial 17 Fallopian Tube Neoplasms 14 Adenocarcinoma of Lung 13 Neuroblastoma 10 Central Nervous System Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Head and Neck Neoplasms 8 Brenner Tumor 7 Brain Neoplasms 7 Urinary Bladder Neoplasms 6 Adenocarcinoma, Bronchiolo-Alveolar 6 Urethral Neoplasms 5 Breast Neoplasms 5 Astrocytoma 5 Wilms Tumor 4 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Medulloblastoma 4 Teratoma 3 Radiation Injuries 3 Optic Nerve Glioma 3 Lymphoma 3 Carcinoma, Renal Cell 3 Carcinoma, Embryonal 3 Carcinoma 3 Thymoma 2 Testicular Neoplasms 2

Interventions

Cisplatin 3 Taxes 2 Psychiatric Rehabilitation 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Etoposide 2 rubitecan 1 pembrolizumab 1 monalizumab 1 marimastat 1 etoposide phosphate 1 durvalumab 1 ceralasertib 1 carfilzomib 1 atezolizumab 1 Watchful Waiting 1 Sunitinib 1 Specimen Handling 1 Radiotherapy, Conformal 1 Polymerase Chain Reaction 1 Platinum Compounds 1 PM 01183 1 Nivolumab 1 NK Cell Lectin-Like Receptor Subfamily C 1 Mental Status and Dementia Tests 1 Isotretinoin 1 Irinotecan 1 Ipilimumab 1 Introns 1 Interferon-alpha 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02580994 2023-12-11

REACTION

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡